The Würzburg cancer researcher Dr. Markus Diefenbacher. (Image: Benedikt Knüttel, BKfotofilm)
The Würzburg cancer researcher Dr. Markus Diefenbacher. (Image: Benedikt Knüttel, BKfotofilm) Great recognition for translational cancer researcher Dr. Markus Diefenbacher: He was nominated as Associated Editor of the journal Oncogene. Dr. Markus Diefenbacher is a group leader at the Mildred Scheel Early Career Centre for Cancer Research (MSNZ) of the University of Würzburg and the University Hospital Würzburg. He has been nominated as Associated Editor of the Nature Publishing Group's journal Oncogene with effect from 1 June 2023. Diefenbacher will be the only German scientist to represent the renowned journal for the next three years. The appointment is tantamount to an award for his research on the influence of the ubiquitin system on tumour development. " Oncogene has gained an excellent reputation in tumour research, and I am honoured to be part of this renowned journal as an Associated Editor," says the Würzburg scientist.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
